Literature DB >> 32576017

Efficacy and safety of radiotherapy for primary liver cancer.

Wenqi Chen1, Chi-Leung Chiang2, Laura A Dawson3.   

Abstract

Primary liver cancer includes hepatocellular carcinoma (HCC, 75-85%) and intrahepatic cholangiocarcinoma (10-15%). The vast majority of patients with primary HCC are not candidates for surgical treatment. Surgical resection, liver transplantation and percutaneous puncture are effective potentially curable treatments for patients with early stage liver cancer. Radiation therapy is a non-surgical alternative treatment that has generally been used to treat patients with advanced liver cancer, although it's use in the potentially curative setting is increasing. Radiotherapy is a non-invasive local treatment which works through ionizing radiation. This review summarizes the efficacy and safety of commonly used radiotherapy methods, and reviews three-dimensional conformal radiotherapy (3DCRT), intensity modulated radiation therapy (IMRT), stereotactic body radiotherapy (SBRT), volume-modulated arc therapy (VMAT), and internal radiation therapies, for primary liver cancer (in particular for HCC).

Entities:  

Keywords:  Primary liver cancer; hepatocellular carcinoma (HCC); internal radiation therapy; radiotherapy; tumor

Year:  2020        PMID: 32576017     DOI: 10.21037/cco-20-89

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  1 in total

1.  Effects of alendronate combined with local radiotherapy on serum Akt/GSK3β and bone metabolism levels in patients with bone metastases from primary liver cancer.

Authors:  Lin Chen; Weina Zhu; Shenghao Zhu; Quanhua Ding
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.